BOSTON SCIENTIFIC CORP — Director's Dealing 2015

Jun 1, 2015

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: BOSTON SCIENTIFIC CORP (BSX)
CIK: 0000885725
Period of Report: 2015-05-29

Reporting Person: Nanavaty Maulik (SVP & Pres, Neuromodulation)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2015-05-29	Common Stock	M	50466.0000	$7.1600	Acquired	185000.0000	Direct
2015-05-29	Common Stock	M	21092.0000	$6.2800	Acquired	206092.0000	Direct
2015-05-29	Common Stock	S	71558.0000	$18.5204	Disposed	134534.0000	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2015-05-29	Stock Option (Right to Buy)	$6.2800	M	21092.0000	Disposed	2022-02-27	Common Stock (21092.0000)	Direct
2015-05-29	Stock Option (Right to Buy)	$7.1600	M	50466.0000	Disposed	2021-02-28	Common Stock (50466.0000)	Direct

Footnotes

F1: Includes shares acquired under the Boston Scientific Global Employee Stock Purchase Plan based upon the most current data available.

F2: Represents the weighted average sale price. These shares were sold in multiple transactions at prices ranging from $18.51 to $18.55, inclusive. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.

F3: Grant to the reporting person of an option to purchase a specified number of shares of common stock vesting in four equal annual installments beginning on February 27, 2013, the first anniversary of the date of grant.

F4: Grant to the reporting person of an option to purchase a specified number of shares of common stock vesting in four equal annual installments beginning on February 28, 2012, the first anniversary of the date of grant.